Senti Biosciences SNTI Q4 2025 Annual earnings
Reported March 27, 2026 · Before market open
Revenue$22.0KMiss by $978.0K
EPS-$0.38Beat by $0.05
Revenue estimate$1.0M
EPS estimate-$0.43
Next report
Aug 6, 2026 (In 1 week)Revenue estimate$14.9K
EPS estimate-$0.33
Versus estimates
Revenue
Diluted EPS
Ask the moment Senti Biosciences reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Senti Biosciences report Q4 2025 earnings?
- Senti Biosciences (SNTI) reported Q4 2025 earnings on March 27, 2026 before market open.
- What were Senti Biosciences's Q4 2025 revenue and EPS?
- Senti Biosciences reported revenue of $22.0K and eps of $-0.38 for Q4 2025.
- Did Senti Biosciences beat estimates in Q4 2025?
- Revenue missed the consensus estimate of $1.0M by $978.0K. EPS beat the consensus estimate of $-0.43 by $0.05.
- How did Senti Biosciences's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 99.6% from $5.9M a year earlier and eps grew 43.3% from $-0.67.
- Where can I find Senti Biosciences's Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001628280-26-021578) and the 10-K periodic report (0001628280-26-021580) directly on SEC EDGAR. The filing index links above go to sec.gov.